Research › Learning & Development
A Report on Phosphatidylcholine Therapy in a down Syndrome Child
STS Instructor Authored by David Cantor
Share
Study at a glance
- Area
- Learning & Development
- Study type
- Case study
- Authors
- Cantor DS, Thatcher RW, Ozand P, Kumin L, Rothschild J
- Journal
- Psychological Reports
- Year
- 1986
- Participants
- 1
- Population
- Children
- Protocol
- phosphatidylcholine supplementation with EEG monitoring
- Sessions
- 7 months of supplementation
Key findings
- EEG measures normalized during supplementation
- Some abnormalities came back during a placebo phase
- Speech, language and motor gains exceeded those of comparable peers
- Preliminary single-case data from a larger study in progress
A single-case report in which a two-and-a-half-year-old boy with Down syndrome took a phosphatidylcholine supplement for seven months, based on the idea that the cholinergic system is impaired in Down syndrome. His EEG moved toward normal during treatment, with some abnormalities returning during a placebo period. His speech, language and motor skills improved beyond those of peers with Down syndrome in similar programs; the authors stress the data are preliminary.